SELVAS Healthcare, Inc. agreed to acquire a 2.72% stake in Ultrasight Ltd. for KRW 1.4 billion on June 12, 2023. The board of directors of SELVAS Healthcare, Inc have resolved the transaction. The transaction is expected to be closed by June 15, 2023.

As of year ended 2022, Ultrasight Ltd reported total assets of KRW 9,185 million and net income of KRW -4,913 million.